Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor have?
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor has 9 citations in the OpenAlex counts ScholarIQ stores.
When was Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor published?
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor has 2007 year in the ScholarIQ index.
What is the open-access status of Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor?
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor has closed oa status in the ScholarIQ index.
What is the DOI of Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor?
The DOI for Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor is on the source record.
What is the PMID of Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor?
The PMID for Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor is on the source record.
What is the OpenAlex record for Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor?
The OpenAlex for Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia changes in serum potassium levels with or without a RAAS inhibitor is on the source record.